AMD Clinical Trial - Study to Evaluate the Response to Supplementation

See also
Status	Clinical Trial	Phase
Recruiting	`NCT01432847` - Cell Collection to Study Eye Diseases
Recruiting	`NCT03893474` - Quality-Assured Follow-up of Quiescent Neovascular Age -Related maculaR dEgeneration by Non-medical Practitioners	N/A
Completed	`NCT00971464` - Low Vision Study Comparing EV Training vs. CCTV for AMD Rehabilitation	Phase 2
Terminated	`NCT00332657` - Anecortave Acetate Risk Reduction Trial (AART)	Phase 3
Recruiting	`NCT04796545` - Post-market Clinical Investigation of the SING IMT System, Model NG SI IMT 3X in Patients With End-stage Age-related Macular Degeneration	N/A
Completed	`NCT01766596` - Study the Signs of Ocular Degeneration in a Population Cohort (Dijon 3C Montrachet Cohort)	N/A
Completed	`NCT03322930` - Rod Sensitivity in Age-related Macular Degeneration (AMD) and Retinitis Pigmentosa (RP)
Completed	`NCT01778491` - AMD Phenotype and Genotype Study
Completed	`NCT01016873` - INTREPID - IRay Plus Anti-VEGF Treatment For Patients With Wet AMD	Phase 2
Active, not recruiting	`NCT03845582` - Phase 3 Study of ALK-001 in Geographic Atrophy	Phase 3
Completed	`NCT03372746` - Generation of Induced Pluripotent Stem (iPS) Cell Lines From Skin Fibroblast Cells of Participants With Age-Related Macular Degeneration
Completed	`NCT03367767` - Age-Related Eye Disease Study 2 (AREDS2) 10-year Follow-On
Terminated	`NCT00333216` - Anecortave Acetate Risk-Reduction Trial (AART)	Phase 3
Completed	`NCT01570790` - Combretastatin A4 Phosphate in Patients With Neovascular Age-Related Macular Degeneration	Phase 1/Phase 2
Completed	`NCT00346866` - Anecortave Acetate Versus Placebo in AMD Patients Following PDT	Phase 2
Withdrawn	`NCT00726466` - Study of Efalizumab Combined With Intravitreal Ranibizumab in the Treatment of Age-Related Macular Degeneration	Phase 1
Completed	`NCT00306488` - OT-551 Antioxidant Eye Drops to Treat Geographic Atrophy in Age-Related Macular Degeneration	Phase 2
Terminated	`NCT02348359` - X-82 to Treat Age-related Macular Degeneration	Phase 2
Completed	`NCT01632527` - Study of Human Central Nervous System Stem Cells (HuCNS-SC) in Age-Related Macular Degeneration (AMD)	Phase 1/Phase 2
Withdrawn	`NCT01339949` - Study to Evaluate the Safety and Effectiveness of IRay in Wet Age-related Macular Degeneration (AMD) Patients With Recurrent Leakage Secondary to Choroidal Neovascularisation (CNV)	N/A

NCT number	NCT05056025
Study type	Interventional
Source	Institut de la Macula y la Retina
Contact	Jordi Mones, MD PhD
Phone	+34 935 950 155
Email	jmones@institutmacula.com
Status	Recruiting
Phase	N/A
Start date	December 2, 2020
Completion date	January 2024

Study to Evaluate the Response to Supplementation With Postbiotics in Patients With Macular Degeneration. — REVERS

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms